Found: 141
Select item for more details and to access through your institution.
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1540, doi. 10.1002/ajh.27023
- By:
- Publication type:
- Article
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1277, doi. 10.1002/ajh.26990
- By:
- Publication type:
- Article
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
- By:
- Publication type:
- Article
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 413, doi. 10.1002/ajh.26806
- By:
- Publication type:
- Article
Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
- By:
- Publication type:
- Article
Overexpression of the energy metabolism transcriptome within clonal plasma cells is associated with the pathogenesis and outcomes of patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 895, doi. 10.1002/ajh.26577
- By:
- Publication type:
- Article
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 267, doi. 10.1002/ajh.26439
- By:
- Publication type:
- Article
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 209, doi. 10.1002/ajh.26422
- By:
- Publication type:
- Article
Prognostic significance of acquired 1q22 gain in multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 52, doi. 10.1002/ajh.26391
- By:
- Publication type:
- Article
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1131, doi. 10.1002/ajh.26269
- By:
- Publication type:
- Article
Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
- By:
- Publication type:
- Article
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E157, doi. 10.1002/ajh.26125
- By:
- Publication type:
- Article
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. 446, doi. 10.1002/ajh.26092
- By:
- Publication type:
- Article
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first‐line therapy in multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 330, doi. 10.1002/ajh.26074
- By:
- Publication type:
- Article
Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. E35, doi. 10.1002/ajh.26023
- By:
- Publication type:
- Article
Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratio.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 11, p. 1280, doi. 10.1002/ajh.25940
- By:
- Publication type:
- Article
Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 497, doi. 10.1002/ajh.25746
- By:
- Publication type:
- Article
Enhancing the R‐ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 310, doi. 10.1002/ajh.25709
- By:
- Publication type:
- Article
Implications and outcomes of MRD‐negative multiple myeloma patients with immunofixation positivity.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. E60, doi. 10.1002/ajh.25702
- By:
- Publication type:
- Article
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 274, doi. 10.1002/ajh.25697
- By:
- Publication type:
- Article
Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. 4, doi. 10.1002/ajh.25657
- By:
- Publication type:
- Article
Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E8, doi. 10.1002/ajh.25654
- By:
- Publication type:
- Article
Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 10, p. 1066, doi. 10.1002/ajh.25572
- By:
- Publication type:
- Article
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 1020, doi. 10.1002/ajh.25566
- By:
- Publication type:
- Article
Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. 751, doi. 10.1002/ajh.25481
- By:
- Publication type:
- Article
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. E141, doi. 10.1002/ajh.25440
- By:
- Publication type:
- Article
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi‐parametric flow cytometry method.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. 424, doi. 10.1002/ajh.25391
- By:
- Publication type:
- Article
Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 306, doi. 10.1002/ajh.25365
- By:
- Publication type:
- Article
Utility and prognostic value of <sup>18</sup>F‐FDG positron emission tomography‐computed tomography scans in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1518, doi. 10.1002/ajh.25279
- By:
- Publication type:
- Article
Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1384, doi. 10.1002/ajh.25254
- By:
- Publication type:
- Article
Serum free light chain measurements to reduce 24‐h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1207, doi. 10.1002/ajh.25215
- By:
- Publication type:
- Article
Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 889, doi. 10.1002/ajh.25113
- By:
- Publication type:
- Article
Efficacy of VDT PACE‐like regimens in treatment of relapsed/refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 179, doi. 10.1002/ajh.24954
- By:
- Publication type:
- Article
<italic>MYD88</italic> mutation status does not impact overall survival in Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 187, doi. 10.1002/ajh.24955
- By:
- Publication type:
- Article
Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 17, doi. 10.1002/ajh.24919
- By:
- Publication type:
- Article
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1146, doi. 10.1002/ajh.24883
- By:
- Publication type:
- Article
POEMS syndrome: An elusive diagnosis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1269, doi. 10.1002/ajh.24845
- By:
- Publication type:
- Article
The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. E507, doi. 10.1002/ajh.24807
- By:
- Publication type:
- Article
Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 668, doi. 10.1002/ajh.24745
- By:
- Publication type:
- Article
Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. 549, doi. 10.1002/ajh.24723
- By:
- Publication type:
- Article
Hematology patient reported symptom screen to assess quality of life for AL amyloidosis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 435, doi. 10.1002/ajh.24676
- By:
- Publication type:
- Article
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. 50, doi. 10.1002/ajh.24582
- By:
- Publication type:
- Article
Outcomes of patients with renal monoclonal immunoglobulin deposition disease.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 11, p. 1123, doi. 10.1002/ajh.24528
- By:
- Publication type:
- Article
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 11, p. 1129, doi. 10.1002/ajh.24532
- By:
- Publication type:
- Article
Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. 984, doi. 10.1002/ajh.24453
- By:
- Publication type:
- Article
Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 585, doi. 10.1002/ajh.24356
- By:
- Publication type:
- Article
Limiting early mortality: Do's and don'ts in the management of patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 1, p. 101, doi. 10.1002/ajh.24129
- By:
- Publication type:
- Article
Sex-based disparities in venous thromboembolism outcomes: A National Inpatient Sample (NIS)-based analysis.
- Published in:
- Vascular Medicine, 2017, v. 22, n. 2, p. 121, doi. 10.1177/1358863X17693103
- By:
- Publication type:
- Article
Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 351, doi. 10.1111/ejh.14246
- By:
- Publication type:
- Article
Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti‐CD38 monoclonal antibody.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 2, p. 318, doi. 10.1111/ejh.14008
- By:
- Publication type:
- Article